Is MetLife (MET) a risky stock?
As of July 21, 2026, Clavix grades MetLife (MET) B for risk, a composite score of 74 out of 100 on an A+ to F scale, which puts MET in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind MET's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how MET scores on each, as of July 21, 2026.
What's moving MET's risk right now
Company-specific signals Clavix flags behind MET's current grade, drawn from recent news and filings as of July 21, 2026.
MetLife filed an 8-K material event report with the SEC on July 20, 2026. Details of what the filing covered aren't included in the available evidence.
What a B grade means
On the Clavix A+ to F scale, MET's composite of 74 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell MET or any security. Grades are risk indicators, not predictions of return. Data may be delayed.